MedPath

Effect of Olmesartan on Endothelial Dysfunction After Everolimus Eluting Stent Implantatio

Not Applicable
Conditions
hypertension and coronary artery disease
Registration Number
JPRN-UMIN000007728
Lead Sponsor
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Recent myocardial infarction (within the previous 48 hours). 2. An ejection fraction of less than 40%. 3. An unprotected left main coronary artery disease. 4. A history of coronary artery vasospasm. 5. Severe calcified or adherence of thrombus in target vessel. 6. Bilateral renal artery stenosis or unilateral renal artery stenosis of remnant kidney. 7. Hyperkalemia (serum kalium>5.0mEq/L). 8. Renal insufficiency (serum creatinnin > 3.0 mg/dL). 9. Liver function disorder (AST or ALT > 100 U/L). 10. Expectant mother. 11. Inappropriate patients judged by the physician in charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
endothelial function
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath